Latest news
Desmoid Tumours Are Not Benign to the People Living With Them
FDA has accepted Immunome’s NDA for varegacestat in adults with progressing desmoid tumours. The label may say non-metastatic. The burden can still be brutal.
Measles Is Finding the Holes in America’s Protection Map
ESC Cardio-Oncology 2026: Cancer therapy is getting smarter. Cardiac protection is still playing catch-up.
ENDO 2026 reveals the GLP-1 revolution’s real challenge: delivery
Gastric Cancer Gets a New Biomarker Access Signal
Prostate Cancer Access Moves Into the Veterans System
Brain-Bleed Care Still Has a Last-Mile Problem
Mental Health Patients Need Care, Not Surveillance
Hepatitis A Shows What Happens When Water Systems Fail People
Ebola Funding Finally Moves. The Virus Has Already Moved Faster.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.